APx Acquisition Corp. I (APXI) 10-Q28 Feb 242023 Q3 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	9 Months Ended
Cover Page - shares	Sep. 30, 2023	Feb. 28, 2024
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Transition Report	false
Entity Registrant Name	APX ACQUISITION CORP. I
Entity Central Index Key	0001868573
Document Period End Date	Sep. 30, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity File Number	001-41125
Entity Tax Identification Number	00-0000000
Entity Incorporation, State or Country Code	E9
Entity Address, Country	TN
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	APXI
Security Exchange Name	NASDAQ
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Interactive Data Current	Yes
Entity Address, Address Line One	714 Westview Avenue
Entity Address, City or Town	Nashville
Entity Address, Postal Zip Code	37205
City Area Code	202
Local Phone Number	465-5882
Document Quarterly Report	true
Capital Units [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, par value $0.0001, and one-half of one redeemable warrant
Trading Symbol	APXIU
Security Exchange Name	NASDAQ
Warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of Class A common stock for $11.50 per share
Trading Symbol	APXIW
Security Exchange Name	NASDAQ
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		9,910,124
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		0

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash	$ 9,369	$ 413,206
Prepaid expenses	25,000	137,500
Total Current Assets	34,369	550,706
Investment held in Trust Account	63,424,707	177,952,202
Total Assets	63,459,076	178,502,908
Current liabilities
Accrued expenses and accounts payable	77,258	751,538
Working capital promissory note, convertible	125,000	0
Total current liabilities	202,258	751,538
Warrant liabilities	657,305	351,500
Total Liabilities	859,563	1,103,038
Commitments and Contingencies (Note 6)
Class A ordinary shares; 5,799,120 and 17,250,000 shares subject to possible redemption at $10.94 and 10.32 per share redemption value at September 30, 2023 and December 31, 2022, respectively	63,424,707	177,952,202
Shareholders' Deficit
Preferred Stock - $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at September 30, 2023 and December 31, 2022	0	0
Additional paid-in capital	0	0
Accumulated Deficit	(825,625)	(552,763)
Total Shareholders' Deficit	(825,194)	(552,332)
TOTAL LIABILITIES, CLASS A ORDINARY SHARE SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT	63,459,076	178,502,908
Common Class A [Member]
Shareholders' Deficit
Common Stock Value	0	0
Common Class B [Member]
Shareholders' Deficit
Common Stock Value	$ 431	$ 431

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Temporary equity shares outstanding	5,799,120	17,250,000
Temporary Equity, Redemption Price Per Share	$ 10.94	$ 10.32
Preferred stock par or stated value per share	$ 0.0001	$ 0.0001
Preferred stock shares authorized	1,000,000	1,000,000
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Common Class A [Member]
Temporary equity shares outstanding	5,799,120	17,250,000
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	200,000,000	200,000,000
Common stock shares issued	200,000	200,000
Common stock shares outstanding	200,000	200,000
Common Class B [Member]
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	20,000,000	20,000,000
Common stock shares issued	4,312,500	4,312,500
Common stock shares outstanding	4,312,500	4,312,500

Condensed Statement of Operatio

Condensed Statement of Operations - USD ($)	3 Months Ended		9 Months Ended
Condensed Statement of Operations - USD ($)	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Formation costs and other operating expenses	$ 188,108	$ 399,470	$ 1,550,407	$ 905,833
Loss from operations	(188,108)	(399,470)	(1,550,407)	(905,833)
Other Income (expense):
Income earned on investments in Trust Account	900,532	462,704	3,467,067	722,006
One-time advisory fee	1,625,000	0	1,625,000	0
Gain on settlement of deferred underwriting fees	0	249,047	0	249,047
Gain on settlement of debt	117,373	0	117,373	0
Interest expense	(24,442)	0	(82,345)	0
Change in FV of warrant liability	572,794	175,750	(340,833)	10,826,200
Gain on settlement of trade payables	878,886	0	878,886	0
Total Other Income (expense), net	4,070,143	887,501	5,665,148	11,797,253
Net income	3,882,035	548,031	$ 4,114,741	10,891,420
Weighted average shares outstanding diluted			17,575,000
Common Class A [Member]
Other Income (expense):
Net income	$ 2,328,684	$ 438,425	$ 2,762,058	$ 8,713,136
Weighted average shares outstanding basic	6,465,022	17,250,000	8,805,742	17,250,000
Weighted average shares outstanding diluted	6,465,022	17,250,000	8,805,742	17,250,000
Basic net income per share	$ 0.36	$ 0.03	$ 0.31	$ 0.51
Diluted net income share	$ 0.36	$ 0.03	$ 0.31	$ 0.51
Common Class B [Member]
Other Income (expense):
Net income	$ 1,553,351	$ 109,606	$ 1,352,683	$ 2,178,284
Weighted average shares outstanding basic	4,312,500	4,312,500	4,312,500	4,312,500
Weighted average shares outstanding diluted	4,312,500	4,312,500	4,312,500	4,312,500
Basic net income per share	$ 0.36	$ 0.03	$ 0.31	$ 0.51
Diluted net income share	$ 0.36	$ 0.03	$ 0.31	$ 0.51

Condensed Statement of Changes

Condensed Statement of Changes In Shareholders' Deficit - USD ($)	Total	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Common Class B [Member]	Common Class B [Member] Common Stock [Member]
Beginning balance at Dec. 31, 2021	$ (17,175,093)	$ 0	$ (17,175,524)		$ 431
Beginning balance (Shares) at Dec. 31, 2021					4,312,500
Net income	7,660,967		7,660,967
Ending balance at Mar. 31, 2022	(9,514,126)	0	(9,514,557)		$ 431
Ending balance (Shares) at Mar. 31, 2022					4,312,500
Beginning balance at Dec. 31, 2021	(17,175,093)	0	(17,175,524)		$ 431
Beginning balance (Shares) at Dec. 31, 2021					4,312,500
Remeasurement of Class A ordinary share to redemption amount	(722,900)
Net income	10,891,420			$ 2,178,284
Ending balance at Sep. 30, 2022	(1,218,120)	0	(1,218,551)		$ 431
Ending balance (Shares) at Sep. 30, 2022					4,312,500
Beginning balance at Mar. 31, 2022	(9,514,126)	0	(9,514,557)		$ 431
Beginning balance (Shares) at Mar. 31, 2022					4,312,500
Remeasurement of Class A ordinary share to redemption amount	(260,196)		(260,196)
Net income	2,682,422		2,682,422
Ending balance at Jun. 30, 2022	(7,091,900)	0	(7,092,331)		$ 431
Ending balance (Shares) at Jun. 30, 2022					4,312,500
Remeasurement of Class A ordinary share to redemption amount	(462,704)		(462,704)
Gain on settlement of underwriting fees	5,788,453		5,788,453
Net income	548,031		548,031	109,606
Ending balance at Sep. 30, 2022	(1,218,120)	0	(1,218,551)		$ 431
Ending balance (Shares) at Sep. 30, 2022					4,312,500
Beginning balance at Dec. 31, 2022	(552,332)	0	(552,763)		$ 431
Beginning balance (Shares) at Dec. 31, 2022					4,312,500
Remeasurement of Class A ordinary share to redemption amount	(1,769,011)		(1,769,011)
Net income	120,845		120,845
Ending balance at Mar. 31, 2023	(2,200,498)	0	(2,200,929)		$ 431
Ending balance (Shares) at Mar. 31, 2023					4,312,500
Beginning balance at Dec. 31, 2022	(552,332)	0	(552,763)		$ 431
Beginning balance (Shares) at Dec. 31, 2022					4,312,500
Remeasurement of Class A ordinary share to redemption amount	(5,092,067)
Net income	4,114,741			1,352,683
Ending balance at Sep. 30, 2023	(825,194)	0	(825,625)		$ 431
Ending balance (Shares) at Sep. 30, 2023					4,312,500
Beginning balance at Mar. 31, 2023	(2,200,498)	0	(2,200,929)		$ 431
Beginning balance (Shares) at Mar. 31, 2023					4,312,500
Remeasurement of Class A ordinary share to redemption amount	(2,297,524)		(2,297,524)
Net income	111,861		111,861
Ending balance at Jun. 30, 2023	(4,386,161)	0	(4,386,592)		$ 431
Ending balance (Shares) at Jun. 30, 2023					4,312,500
Remeasurement of Class A ordinary share to redemption amount	(1,025,532)	(704,464)	(321,068)
Gain on settlement of related party payables	704,464	704,464
Net income	3,882,035		3,882,035	$ 1,553,351
Ending balance at Sep. 30, 2023	$ (825,194)	$ 0	$ (825,625)		$ 431
Ending balance (Shares) at Sep. 30, 2023					4,312,500

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows - USD ($)	3 Months Ended				9 Months Ended		12 Months Ended
Condensed Statements of Cash Flows - USD ($)	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Cash Flows from Operating Activities
Net income	$ 3,882,035	$ 120,845	$ 548,031	$ 7,660,967	$ 4,114,741	$ 10,891,420
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Change in fair value of warrant liabilities					340,833	(10,826,200)
Interest earned on marketable securities held in trust					(3,467,067)	(722,006)
Gain on settlement of deferred underwriting fees	0		(249,047)		0	(249,047)	$ (249,047)
Gain on settlement of debt	(117,373)		0		(117,373)	0
Gain on settlement of trade payables	(878,886)		0		(878,886)	0
Amortization of debt discount					82,345	0
Changes in operating assets and liabilities:
Prepaid expenses					112,500	112,500
Accounts payable and accrued expenses					909,070	368,164
Net cash provided by (used in) operating activities					1,096,163	(425,169)
Cash flow from investing activities:
Cash deposited into Trust Account					(1,625,000)	0
Investments withdrawn from Trust Account for redemptions					119,619,562	0
Net cash provided by investing activities					117,994,562	0
Cash flow from financing activities:
Proceeds received from promissory note					1,625,000	0
Repayment of promissory note					(1,625,000)	0
Proceeds received from working capital promissory note, convertible					125,000	0
Payments of redemption for Class A Common Stock					(119,619,562)	0
Net cash used in financing activities					(119,494,562)	0
Net change in cash					(403,837)	(452,169)
Cash - Beginning of period		413,206		$ 953,432	413,206	953,432	953,432
Cash - End of Period	9,369		528,263		9,369	528,263	413,206
Non-cash investing and financing activities:
Remeasurement of Class A shares subject to possible redemption	$ 1,025,532	$ 1,769,011	$ 462,704		5,092,067	722,900
Gain on settlement of underwriting fees					0	5,788,453	$ 5,788,453
Gain on settlement of related party payables					$ 704,464	$ 0

Description Of Organization, An

Description Of Organization, And Business Operations And Going Concern	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description Of Organization, And Business Operations And Going Concern	NOTE 1. DESCRIPTION OF ORGANIZATION, AND BUSINESS OPERATIONS AND GOING CONCERN APx Acquisition Corp. I (the “Company”) is a blank check company incorporated in the Cayman Islands on May 13, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2023, the Company had not yet commenced any operations. All activity for the period May 13, 2021 (inception) through September 30, 2023, relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) which is described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. The Company’s sponsor is APx Cap Sponsor Group I, LLC (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on December 6, 2021. On December 9, 2021, the Company consummated the Initial Public Offering of 17,250,000 units (the “Units” and, with respect to the shares of Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $172,500,000, which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 8,950,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) to the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $8,950,000 (Note 4). Transaction costs amounted to $10,321,097, consisting of $3,450,000 of underwriting fees, $6,037,500 of deferred underwriting fees and $833,597 of other offering costs. In addition, at December 9, 2021, cash of $ 1,295,936 was held outside of the Trust Account (as defined below) and is available for working capital purposes. On October 17, 2022, the Company entered into an engagement letter with EarlyBirdCapital, Inc. (“EBC”) for the provision of M&A advisory services (the “Advisory Agreement”) and an engagement letter with EBC for placement agency services (the “Placement Agency Agreement”). Pursuant to the Advisory Agreement, the Company would pay to EBC a fee of $2,000,000 in cash upon the closing of a business combination or similar transaction (the “Transaction Fee”). Pursuant to the Placement Agency Agreement, the Company would pay to EBC upon the closing of a business combination or similar transaction a cash placement fee (the “Placement Agent Fee”) equal to (a) 4.5% of the aggregate equity amount funded by investors contacted by EBC in connection with the placement, and (b) 2.5% of the aggregate debt financing amount, including secured and convertible debt, funded by investors contacted by EBC in connection with the placement. On August 22, 2023, the Company and EBC entered into a letter agreement (the “Letter Amendment”) which terminated the Placement Agency Agreement (including, for the avoidance of doubt, the Placement Agent Fee) and amended the Advisory Agreement. Pursuant to the Letter Amendment, the Advisory Agreement was amended to provide that the Company, at its option, could elect to pay up to $500,000 of the Transaction Fee in ordinary shares of the post-business combination company (in lieu of cash), with such issuance to occur on the six month anniversary of the closing of the business combination, and valued based on the volume weighted average price of the post-business combination company’s ordinary shares for the ten trading days immediately preceding the six month anniversary of the closing of the business combination. On February 27, 2023, the Company held an extraordinary general meeting (the “February 2023 EGM”) and its shareholders approved an amendment to our amended and restated memorandum and articles of association (as amended, the “Articles of Association”) and to the investment management trust agreement dated as of September 7, 2021 (as amended, the “Trust Agreement”) to change the payment required to extend the Combination Period by two three-month periods (the “February Extension Amendment Amendment”). In connection with such vote, the holders of public shares properly exercised their right to redeem their shares (and did not withdraw their redemption) for an aggregate redemption amount of $ . Following such redemptions, approximately $ remained in the trust account and public shares remained issued and outstanding. Such remaining amount in the trust account will be distributed either to (i) all holders of public shares upon our liquidation or (ii) holders of public shares who elect to have their shares redeemed in connection with the consummation of our initial business combination. Accordingly, on March 1, 2023, the Company deposited $ into the Trust Account in order to effect the extension of the termination date, from March 9, 2023 to June 9, 2023 (the “First Extension”). On June 22, 2023, the Company deposited an additional $ into the Trust Account for a subsequent extension of the termination date, from June 9, 2023 to September 9, 2023 (the “Second Extension”), that the Company may need to complete an initial business combination. On September 7, 2023, the Company held an extraordinary general meeting (the “September 2023 EGM”) and its shareholders approved an amendment to its Articles and to the Trust Agreement to extend the time to complete a business combination (the “Termination Date”) up to three (3) times for an additional one (1) month each time (each, an “Extension”) from September 9, 2023 to December 9, 2023, by depositing the lesser of $0.025 per public share or $125,000 (each such payment, an “Extension Payment”) for each one-month extension into the Company’s trust account (the “Trust Account”). In connection with the September 2023 EGM, the holders of 757,463 public shares properly exercised their right to redeem their shares (and did not withdraw their redemption) for an aggregate redemption amount of approximately $8,273,281. Following such redemptions, approximately $63,340,058 remained in the trust account and 5,799,120 public shares remained issued and outstanding. Such remaining amount in the trust account will be distributed either to (i) all holders of public shares upon our liquidation or (ii) holders of public shares who elect to have their shares redeemed in connection with the consummation of our initial business combination. On September 8, 2023, the Company entered into a purchase agreement (the “Purchase Agreement”) with the Company’s sponsor, APx Cap Sponsor Group I, LLC (the “Sponsor”) and Templar, LLC and its designees (the “Purchaser”), whereby the Sponsor transferred to the Purchaser, in exchange for $1.00 plus the Purchaser’s agreement to advance up to $50,000 to pay for expenses related to Company’s Exchange Act filing obligations, of the Company’s Class B ordinary shares, $ par value (the “Founder Shares”) and private placement warrants (the “Placement Warrants”) purchased at the time of the Company’s initial public offering (“IPO”) pursuant to a Private Placement Warrants Purchase Agreement, dated December 6, 2021. The Sponsor retained Founder Shares and Private Placement Warrants. The transfer of Founder Shares and Private Placement Warrants to the Purchaser pursuant to the Purchase Agreement is referred to as the “Transfer,” which closed on September 8, 2023. The Transfer and all transactions consummated in connection there with are referred to as the “Sponsor Alliance Transaction.” On September 15, 2023 October 19, 2023 and November 13, 2023, the Company deposited $125,000 into the Trust Account in order to effect three one-month extensions of the termination date, from September 9, 2023 to December 9, 2023. On December 8, 2023, the Company held an extraordinary general meeting (the “December 2023 EGM”) and its shareholders approved an amendment to its Articles and to the Trust Agreement to extend the Termination Date up to twelve (12) times for an additional one (1) month each time from December 9, 2023 to December 9, 2024, by depositing the lesser of $0.025 per public share or $125,000 for each one-month extension into the Company’s Trust Account. In connection with the December 2023 EGM, the holders of 201,496 public shares properly exercised their right to redeem their shares (and did not withdraw their redemption) for an aggregate redemption amount of $2,246,585. Following such redemptions, $62,410,856 remained in the trust account and 5,597,624 public shares remained issued and outstanding. Such remaining amount in the trust account will be distributed either to (i) all holders of public shares upon our liquidation or (ii) holders of public shares who elect to have their shares redeemed in connection with the consummation of our initial business combination. On December 20, 2023, January 10, 2024 and February 9, 2024, the Company deposited $125,000 each month into the Trust Account in order to effect three one-month extensions of the termination date to March 9, 2024. Upon the closing of the Initial Public Offering, an amount of $ from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units was placed in a trust account (the “Trust Account”) located in the United States and will be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (as defined below) (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its holders of the outstanding Public Shares (the “public shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares without voting, and if they do vote, irrespective of whether they vote for or against a Business Combination. If the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Certificate of Incorporation provides that, a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), will be restricted from seeking redemption rights with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent. The public shareholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to shareholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (Note 8). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. These Class A ordinary equity If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Articles, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. The Company’s Sponsor has agreed (a) to vote its Founder Shares (Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s with respect to the Company’s pre-Business Combination activities prior to the closing of a Business Combination unless the Company provides dissenting public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Founder Shares) into the right to receive cash from the Trust Account in connection with a shareholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek shareholder approval in connection therewith) or a vote to amend the provisions of the Articles relating to shareholders’ rights of pre-Business Combination activity and (d) that the Founder Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholder’s rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and the requirements of applicable law. The underwriters have agreed to waive their rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit $10.00. The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure its shareholders that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Liquidity and Capital Resources As of September 30, 2023, the Company had $9,369 in cash and a working capital deficit of $167,889. The Company’s liquidity needs up to September 30, 2023 had been satisfied through a payment from the Sponsor of $25,000 (Note 5) for the Founder Shares and the remaining net proceeds from our Initial Public Offering, the Private Placement Warrants and the Promissory Notes (as defined below), to cover certain offering expenses. In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans, as defined below (Note 6). As of September 30, 2023, there were no amounts outstanding under any Working Capital Loans. On February 28, 2023, the Company issued an unsecured promissory note (the “First Promissory Note”) in the amount of $875,000. The proceeds of the First Promissory Note were drawn in a single instance and will be used to economically facility the Company’s ability to effect the extension of the termination date. The First Promissory Note is payable in full on the earlier of (a) the Company’s consummation of a Business Combination or (b) December 31, 2023. On May 26, 2023, the Company issued a second unsecured promissory note (the “Second Promissory Note”) and, together with the First Promissory Note, the “Promissory Notes”) in the amount of $750,000. The proceeds of the Second Promissory Note were drawn in a single instance and will be used to economically facility the Company’s ability to effect the extension of the termination date. The Second Promissory Note is payable in full on the earlier of (a) the Company’s consummation of a Business Combination or (b) December 31, 2023. On August 18, 2023, the Company paid in full the outstanding balance of $1,625,000 drawn on the First Promissory and Second Promissory Notes, in connection the Company incurred a gain on settlement of debt of $117,373. The Note payable is considered paid in full, and the Company no longer has access to draw funds. On September 8, 2023, in connection with the Sponsor Alliance Transaction outstanding under the Working Capital Promissory Note. Based on the foregoing, management believes that the Company will not have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Going Concern Consideration At September 30, 2023, the Company $9,369 in cash and a working capital deficit of $167,889. The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Account Standards Update (“ASU”) 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The Company has until December 9, 2024 (36 months from the closing of the IPO), if we further extend the period by up to twelve additional one-month periods, to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution as well as insufficient cash flows raises substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustment that might result from the outcome of this uncertainty.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
Summary of Significant Accounting Policies	Sep. 30, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $9,369 and $413,206 in cash and no cash equivalents as of September 30, 2023, and December 31, 2022, respectively. Investment Held in Trust Account As of September 30, 2023, and December 31, 2022, the Company had $63,424,707 and $177,952,202, respectively held in the Trust Account which invests only in direct U.S. government treasury obligations. Share-based Compensation The transfer of the Founder Shares is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, share- based compensation associated with equity-classified awards is measured at fair value upon the grant date. The Founders Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Share-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon occurrence of a Business Combination) in an amount equal to the number of Founders Shares that ultimately vest multiplied by the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares. As of September 30, 2023, the Company determined that a Business Combination is not considered probable and, therefore, no share- based compensation expense has been recognized. The fair value at the grant date of the 40,000 Founder Shares transferred to the Company’s directors was approximately $203,000 or $5.08 per share. Upon consummation of an initial business combination, the Company will recognize approximately $203,000 in compensation expense. Net Income Per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income per share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the periods. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 17,575,000 of the Company’s Class A ordinary shares in the calculation of diluted income per share. The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend for the purposes of the numerator in the earnings per share calculation. Net income per ordinary share is computed by dividing the pro rata net income between the redeemable shares and the non-redeemable shares by the weighted average number of ordinary shares outstanding for each of the periods. The calculation of diluted income per ordinary stock does not consider the effect of the warrants issued in connection with the Initial Public Offering since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except share amounts) for the three and nine months ended September 30, 2023, and 2022: For the Three Months Ended 2023 2022 Class A Ordinary Class B Ordinary Class A Ordinary Class B Ordinary Basic and diluted net income per ordinary share Numerator Allocation of net income $ 2,328,684 $ 1,553,351 $ 438,425 $ 109,606 Denominator Basic and diluted weighted average shares outstanding 6,465,022 4,312,500 17,250,000 4,312,500 Basic and diluted net income per ordinary shares $ 0.36 $ 0.36 $ 0.03 $ 0.03 For the Nine Months Ended 2023 2022 Class A Ordinary Class B Ordinary Class A Ordinary Class B Ordinary Basic and diluted net income per ordinary share Numerator: Allocation of net income $ 2,762,058 $ 1,352,683 $ 8,713,136 $ 2,178,284 Denominator Basic and diluted weighted average shares outstanding 8,805,742 4,312,500 17,250,000 4,312,500 Basic and diluted net income per ordinary shares $ 0.31 $ 0.31 $ 0.51 $ 0.51 Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement re The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. Warrant Liability The Company accounts for warrants based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, “Distinguishing Liabilities from Equity” (“ASC 480”), and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The fair value of the warrants was estimated using a Monte Carlo simulation model-based approach (see Note 11). Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, Derivatives and Hedging. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’ own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. Level 1—Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2—Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3—Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities were expensed as incurred in the condensed consolidated statements of operations. Offering costs associated with the Class A ordinary shares issued were charged to temporary equity and warrants upon the completion of the Initial Public Offering. Offering costs amounting to $10,321,097 were charged to shareholders’ equity upon the completion of the Initial Public Offering and $465,166 were expensed as of the date of the Initial Public Offering. Recently Issued Accounting Standards In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholder’s equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholder’s equity section of the Company’s balance sheet.

Initial Public Offering

Initial Public Offering	9 Months Ended
Initial Public Offering	Sep. 30, 2023
Stockholders' Equity Note [Abstract]
Initial Public Offering	NOTE 3. INITIAL PUBLIC OFFERING On December 9, 2021, the Company sold 17,250,000 Units at $10.00 per Unit, generating gross proceeds of $172.5 million, and incurring offering costs of to $10,321,097, consisting of $3,450,000 of underwriting fees, $6,037,500 of deferred underwriting fees and $833,897 of other offering costs. Each Unit consists of one share of the Company’s Class A ordinary shares, par value $0.0001 per share, and one-half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant will entitle the holder to purchase one share of Class A ordinary shares at an exercise price of $11.50 per whole share (Note 8). In September 2022, the Company reversed the $6,037,500 of deferred underwriting fees as the underwriters resigned from their role in the Business Combination and thereby waived their right of the deferred underwriting commissions (Note 8).

Private Placement

Private Placement	9 Months Ended
Private Placement	Sep. 30, 2023
Stockholders' Equity Note [Abstract]
Private Placement	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor has purchased 8,950,000 Private Placement Warrants at a price of $1.00 per warrant, generating total proceeds of $8,950,000 to the Company. Each Private Placement Warrant is identical to the warrants offered in the Initial Public Offering, except there will be no redemption rights or liquidating distributions from the trust account with respect to Private Placement Warrants when the price per share of Class A ordinary shares equals or exceeds $18.00, which will expire worthless if the Company does not consummate a Business Combination within the Combination Period. On September 8, 2023, as part of the Purchase Agreement between the Company’s Sponsor, APx Cap Sponsor Group I, LLC (the “Sponsor”) transferred to Templar, LLC and its designees (the “Purchaser”), 6,936,250 private placement warrants purchased at the time of the Company’s initial public offering (“IPO”) pursuant to a Private Placement Warrants Purchase Agreement, dated December 6, 2021. The Sponsor retained 2,013,750 Private Placement Warrants. The transfer was executed as part of the Sponsor Alliance Transaction

Related Party Transactions

Related Party Transactions	9 Months Ended
Related Party Transactions	Sep. 30, 2023
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On May 21, 2021, the Company issued an aggregate of 4,312,500 shares of Class B ordinary shares (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000. The Founder Shares include an aggregate of up to 562,500 shares subject to forfeiture by the Sponsor to the extent that the underwriter’s over-allotment is not exercised in full or in part, so that the Sponsor will collectively own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering. As of September 30, 2023, all of the over-allotment units had been settled simultaneously with the close of the Initial Public Offering. No Class B ordinary shares were forfeited or subject to forfeiture. Other than as described above, the Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company’s shareholders having the right to exchange their shares of ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 120 days after the Business Combination, the Founder Shares will be released from the lock-up. On September 8, 2023, as part of the Purchase Agreement between the Company’s Sponsor, APx Cap Sponsor Group I, LLC (the “Sponsor”) transferred to Templar LLC and its designees (the “Purchaser”), 3,342,188 of the Company’s class B ordinary shares, $0.0001 par value (the “Founder Shares”) purchased at the time of the Company’s initial public offering (“IPO”) pursuant to a Private Placement Warrants Purchase Agreement, dated December 6, 2021. The Sponsor retained Transaction Initial Note — Related Party On May 21, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Initial Note”). The Initial Note is non-interest bearing and is payable on the earlier of (i) May 1, 2022 or (ii) the consummation of the Initial Public Offering. As of September 30, 2023, and December 31, 2022, the Company has not drawn on the Initial Note and no longer has access to draw funds. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.00 per warrant. The warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of September 30, 2023, the Company has not drawn any balance and no longer has access to draw funds. Administrative Support Agreement Commencing on the date of the prospectus and until completion of the Company’s initial business combination or liquidation, the Company may reimburse an affiliate of the Sponsor up to an amount of $10,000 per month for office space and secretarial and administrative support provided to members of the Company’s management team. The Company considered this agreement under the guidance of ASC 842, Leases, and determined that this agreement did not meet the definition of a lease. In connection with the Sponsor Alliance Transaction, the Company and APx Sponsor Group I terminated the administrative services agreement as of the end of the September 2023, and the Company ceased paying these monthly fees.

Promissory Note Payable

Promissory Note Payable	9 Months Ended
Promissory Note Payable	Sep. 30, 2023
Debt Disclosure [Abstract]
Promissory Note Payable	NOTE 6. PROMISSORY NOTE PAYABLE On February 28, 2023, the Company issued an unsecured promissory note (the “First Promissory Note”) in an amount of $875,000 in order to economically facilitate their ability to effect the extension of the termination date. An amount of $125,000 was used in order to economically facilitate the extension payment to extend the period from September 9, 2023 to October 9, 2023. The First Promissory Note is payable in full on the earlier of (a) consummation of an initial business combination or (b) December 31, 2023 (the “First Due Date”). On the First Due Date, the Company shall pay to the payee under the First Promissory Note (the “Payee”) the outstanding principal amount of the First Promissory Note in immediately available funds and deliver to the Payee, as interest-in-kind, 875,000 of newly issued warrants. The terms of the warrants are identical to the Private Placement Warrants the Company issued in connection with the Initial Public Offering. The Payee shall be entitled to certain registration rights with respect to the warrants and the shares issuable upon exercise of the warrants. On May 26, 2023, the Company issued a second unsecured promissory note (the “Second Promissory Note” and, together with the First Promissory Note, the “Promissory Notes”) in an amount of $750,000 in order to economically facilitate the ability to effect the extension of the termination date, from June 9, 2023 to September 9, 2023 (the “Second Extension”). The Second Promissory Note is payable in full on the earlier of (a) consummation of an initial business combination or (b) December 31, 2023 (the “Second Due Date”). On the Second Due Date, the Company shall pay to the Payee under the Second Promissory Note the outstanding principal amount of the Second Promissory Note in immediately available funds and deliver to the Payee, as interest-in-kind, 750,000 of newly issued warrants. The terms of the warrants are identical to the Private Placement Warrants the Company issued in connection with the Initial Public Offering. The Payee shall be entitled to certain registration rights with respect to the warrants and the shares issuable upon exercise of the warrants. On August 18, 2023, the Company paid in full the outstanding balance of $1,625,000 drawn on the First Promissory and Second Promissory Notes, in connection the Company incurred a gain on settlement of debt of $117,373. The Promissory Note payable is considered paid in full, and the Company no longer has access to draw funds. The Payee forfeited all newly issued private placement warrants, and the ending debt discount as of September 30, 2023 was $0. On September 8, 2023, in connection with the Sponsor Alliance Transaction, the

Commitments And Contingencies

Commitments And Contingencies	9 Months Ended
Commitments And Contingencies	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments And Contingencies	NOTE 7. COMMITMENTS AND CONTINGENCIES Registration Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans and the Promissory Notes (and in each case holders of their component securities, as applicable) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to our Class A ordinary shares). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriter’s Agreement The Company granted the underwriter a 45-day option to purchase up to 2,250,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. The underwriter exercised all of the over-allotment units simultaneously with the close of the Initial Public Offering. The underwriter was entitled to a cash underwriting discount of 2.00% of the gross proceeds of the Initial Public Offering, or $3,450,000 as the over-allotment option was exercised in full. In addition, the underwriter would be entitled to a deferred fee of three and half percent (3.50%) of the gross proceeds of the Initial Public Offering, or $6,037,500 as the over-allotment option was exercised in full. The deferred fee would become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Effective as of September 28, 2022, the underwriter from the Initial Public Offering resigned and withdrew from their role in the Business Combination and thereby waived their right to the deferred underwriting commissions in the amount of $6,037,500, which the Company has recorded as a gain on settlement of underwriter fees on the statement of shareholders’ equity for the year ended December 31, 2022 for $5,788,453, which represents the original amount recorded to accumulated deficit, and the remaining balance representing the original amount recorded to the statements of operations of $249,047 was recorded for the year ended December 31, 2022. As of September 30, 2023, there are no deferred underwriting commissions outstanding. Structuring Services Agreement On May 18, 2023, Grupo Promotor de Desarrollo e Infraestructura, S.A. de C.V. (“Prodi Capital”) engaged the Company to act as a structuring agent in connection with potential transaction related to a business combination. The Company will be entitled to customary fees in such capacity, with payment due at upon finalization of the advisory services. In connection with the Sponsor Alliance Transaction

Warrant Liability

Warrant Liability	9 Months Ended
Warrant Liability	Sep. 30, 2023
Warrants and Rights Note Disclosure [Abstract]
Warrant Liability	NOTE 8. WARRANT LIABILITY The Company accounted for the 17,575,000 warrants issued in connection with the Initial Public Offering (8,625,000 Public Warrants and 8,950,000 Private Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company has classified each warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the consummation of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Public Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement registering the issuance, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Public Warrants. The Company will use its best efforts to file with the SEC a registration statement covering the shares of Class A ordinary shares issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Redemption of warrants when the price per Class A ordinary share equals or exceeds $ 18.00 • in whole and not in part; • at a price of $0.01 per Warrant; • upon a minimum of 30 days’ prior written notice of redemption, which we refer to as the 30-day redemption period; and • if, and only if, the closing price of our Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders (the “Reference Value”). The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period. If and when the warrants become redeemable by us, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of warrants when the price per Class A ordinary share equals or exceeds $ 10.00 • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive the number of shares determined by reference to the table set forth under “Description of Securities—Warrants—Public Shareholders’ Warrants” based on the redemption date and the “fair market value” of our Class A ordinary shares (as defined below); • if, and only if, the Reference Value (as defined above under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $ 18.00 • if the Reference Value is less than $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like), the private placement warrants must also concurrently be called for redemption on the same terms (except as described herein with respect to a holder’s ability to cashless exercise its warrants) as the outstanding public warrants, as described above. If and when the Public Warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares of common shares upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. The exercise price and number of Class A ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A ordinary shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price. The Private Placement Warrants will be identical to the Public Warrants included in the Units being sold in the Initial Public Offering, except that the Private Placement Warrants will not and the shares of common shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

Shareholders' Deficit

Shareholders' Deficit	9 Months Ended
Shareholders' Deficit	Sep. 30, 2023
Stockholders' Equity Note [Abstract]
Shareholders' Deficit	NOTE 9. SHAREHOLDERS’ DEFICIT Preferred Shares — The Company is authorized to issue 1,000,000 shares of $0.0001 par value preferred shares. As of September 30, 2023, and December 31, 2022, there were no preferred shares issued or outstanding. Class B Ordinary shares — The Company is authorized to issue up to 20,000,000 shares of Class B, $0.0001 par value ordinary shares. Holders of the Company’s ordinary shares are entitled to one vote for each share. At September 30, 2023 and December 31, 2022, there were 4,312,500 Class B ordinary shares issued and outstanding. The shares of Class B ordinary shares will automatically convert into shares of Class A ordinary shares at the time of the Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like. In the case that additional shares of Class A ordinary shares, or equity linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B ordinary shares shall convert into shares of Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding shares of Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A ordinary shares issuable upon conversion of all shares of Class B ordinary shares will equal, in the aggregate, on an as converted basis, 20% of the sum of the total number of all shares of ordinary shares outstanding upon the completion of the Initial Public Offering plus all shares of Class A ordinary shares and equity linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity linked securities issued, or to be issued, to any seller in a Business Combination, and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their shares of Class B ordinary shares into an equal number of shares of Class A ordinary shares, subject to adjustment as provided above, at any time. The Company may issue additional ordinary shares or preferred share to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.

Class A Ordinary Shares Subject

Class A Ordinary Shares Subject to Possible Redemption	9 Months Ended
Class A Ordinary Shares Subject to Possible Redemption	Sep. 30, 2023
Temporary Equity Disclosure [Abstract]
Class A Ordinary Shares Subject to Possible Redemption	NOTE 10. CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit. In February of 2023, in connection with the vote to approve the First Extension and the Trust Amendment, the holders of 10,693,417 Public Shares properly exercised their right to redeem their shares (and did not withdraw their redemption) for cash at a redemption price of approximately $10.41 per share, for an aggregate redemption amount of $111,346,281.Following such redemptions, approximately $68,271,081 remained in the trust account and 6,556,583 public shares remained issued and outstanding. Such remaining amount in the trust account will be distributed either to (i) all holders of public shares upon our liquidation or (ii) holders of public shares who elect to have their shares redeemed in connection with the consummation of our initial business combination. Accordingly, on March 1, 2023, the Company deposited $750,000 into the Trust Account in order to effect the extension of the termination date, from March 9, 2023 to June 9, 2023 (the “First Extension”). On June 22, 2023, the Company deposited an additional $750,000 into the Trust Account for a subsequent extension of the termination date, from June 9, 2023 to September 9, 2023 (the “Second Extension”). In September of 2023, in connection with the shareholders’ vote at the Extraordinary General Meeting, the holders of 757,463 public shares properly exercised their right to redeem their shares (and did not withdraw their redemption) for cash at a redemption price of approximately $10.92 per share, for an aggregate redemption amount of approximately $8,273,281. Following such redemptions 5,799,120 public shares remained issued and outstanding. The remaining amount in the Trust Account will be distributed either to: (i) all of the holders of shares of Class A ordinary shares issued as part of the units sold in the Initial Public Offering (the “Public Shares”) upon the Company’s liquidation or (ii) holders of Public Shares who elect to have their shares redeemed in connection with the consummation of a Business Combination. At December 31, 2022 and September 30, 2023, the Class A ordinary shares subject to possible redemption reflected in the balance sheet is reconciled in the following table: Class A Ordinary Shares Subject to Possible Redemption December 31, 2022 $ 177,952,202 Less: Shares redeemed in February 2023 $ (111,346,281 ) Shares redeemed in September 2023 $ (8,273,281 ) Add: Reameasurement of carrying value to redemption value $ 5,092,067 Class A Ordinary Shares Subject to Possible Redemption September 30, 2023 $ 63,424,707

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	NOTE 11. FAIR VALUE MEASUREMENTS The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following table presents information about the Company’s assets and liabilities that are measured at fair value at September 30, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Level September 30, 2023 December 31, 2022 Assets: Investments held in Trust Account – (1) 1 $ 63,424,707 $ 177,952,202 Liabilities: Warrant Liability - Public Warrants (2) 1 $ 322,575 $ 172,500 Warrant Liability - Private Warrants (2) 2 $ 334,730 $ 179,000 (1) The fair value of the investments held in Trust Account approximates the carrying amount primarily due to the short-term nature. (2) Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period. The estimated fair value of the Public Warrants was transferred from a Level 3 measurement to a Level I measurement during the year ended December 31, 2022, when the Public Warrants were separately listed and traded in an active market. The estimated fair value of the Private Warrants was transferred from a Level 3 measurement to a Level 2 measurement during the year ended December 31, 2022, as the key inputs to the valuation model became directly or indirectly observable from the Public Warrants listed price. There have been no transfers for the nine-month period ended September 30, 2023. Warrants The Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the Balance Sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the statements of operations. Initial Measurement The Warrants were valued using a Monte Carlo simulation model-based approach, which is considered to be a Level 3 fair value measurement. The Monte Carlo simulation model’s primary unobservable input utilized in determining the fair value of the Warrants is the expected volatility of the ordinary shares. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. For periods subsequent to the detachment of the Public Warrants from the Units, the close price of the Public Warrant price will be used as the fair value as of each relevant date. The key inputs into the Monte Carlo simulation model for the Private Placement Warrants and Public Warrants were as follows at initial measurement: Inputs December 9, Risk-free interest rate 1.27 % Expected term (years) 5.0 Expected volatility 15.0 % Exercise price $ 11.50 Stock price $ 9.59 The Company’s use of a Monte Carlo simulation model required the use of subjective assumptions: • The risk-free interest rate assumption was based on the five-year U.S. Treasury rate, which was commensurate with the contractual term of the Warrants, which expire on the earlier of (i) five years after the completion of the initial business combination and (ii) upon redemption or liquidation. An increase in the risk-free interest rate, in isolation, would result in an increase in the fair value measurement of the warrant liabilities and vice versa. • The expected term was determined to be five years, in-line with a typical equity investor assumed holding period • The expected volatility assumption was based on the implied volatility from a set of comparable publicly-traded warrants as determined based on the size and proximity of business combinations by similar special purpose acquisition companies. An increase in the expected volatility, in isolation, would result in an increase in the fair value measurement of the warrant liabilities and vice versa. • The fair value of the Units, which each consist of one Class A ordinary share and one-half of one Public Warrant, represents the closing price on the measurement date as observed from the ticker APXIU. Subsequent Measurement The Warrants are measured at fair value on a recurring basis. At the subsequent measurement dates of September 30, 2023 and December 31, 2022, the Public Warrants and Private Placement Warrants were fair valued using the Monte Carlo Simulation Method. The fair value classification for both the Public Warrants and Private Placement Warrants remains unchanged as Level 3 from their initial valuation. The key inputs into the Monte Carlo simulation model for the Private Placement Warrants and Public Warrants were as follows at subsequent measurement: Inputs September 30, December 31, Risk-free interest rate 4.72 % 4.08 % Expected term (years) 0.58 0.83 Expected volatility 1.14 % 0.35 % Exercise price $ 11.50 $ 11.50 Stock price $ 10.97 $ 10.27 The following table presents the changes in the fair value of the Level 2 warrant liabilities: Private Placement Fair value as of December 31, 2022 $ 179,000 Change in valuation inputs or other assumptions 155,730 Fair value as of September 30, 2023 $ 334,730 Changes in valuation inputs or other assumptions are recognized in the change in fair value of warrant liabilities in the statements of operations.

Subsequent Events

Subsequent Events	9 Months Ended
Subsequent Events	Sep. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	NOTE 12. SUBSEQUENT EVENTS The Company evaluated events that have occurred after the balance s h On October 2, 2023, the Company entered into a Share Exchange Agreement with the Purchaser and the Sponsor (the “Share Exchange Agreement”), pursuant to which each of the Purchaser and the Sponsor exchanged (the “Share Exchange”) all Class B ordinary shares then held (totaling an aggregate of 4,312,500 shares) into Class A ordinary shares. The Company issued 4,312,500 Class A ordinary shares (the “Exchange Shares”) in connection with the Share Exchange. The offer and sale of the Exchange Shares has not been registered under the Securities Act or any state securities laws and the Exchange Shares not be offered or sold in the United States absent registration under the Securities Act or an applicable exemption from registration requirements. Nothing contained in this Quarterly Report on Form 10-Q constitutes an offer to sell, or the solicitation of an offer to buy, any securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful. In the Share Exchange Agreement, each of the Purchaser and the Sponsor represented to the Company that it is an “accredited investor”, as defined in Rule 501 promulgated under the Securities Act, and the Company’s offer and sale of the Exchange Shares have been made in reliance upon the exemption from the registration requirements of the Securities Act. On October 16, 2023, November 10, 2023, December 8, 2023, January 10, 2024 and February 9, 2024 the Company made additional draws of the Working Capital Promissory Note to cover the required one-month extension payments. On October 19, 2023, November 13, 2023, December 20, 2023, January 10, 2024 and February 9, 2024 the Company made additional deposits of the Trust Account in order to effect subsequent one month extensions of the Extended Date, which extended the deadline to consummate the Business Combination to March 9, 2024. On December 8, 2023, the Company held an extraordinary general meeting and its shareholders approved an amendment to its Articles and to the Trust Agreement to extend the Termination Date up to twelve (12) times for an additional one (1) month each time from December 9, 2023 to December 9, 2024, by depositing the lesser of $0.025 per public share or $125,000 for each one-month extension into the Company’s Trust Account. In connection with the December 2023 EGM, the holders of 201,496 public shares properly exercised their right to redeem their shares (and did not withdraw their redemption) for an aggregate redemption amount of $2,246,585. Following such redemptions, $62,410,856 remained in the trust account and 5,597,624 public shares remained issued and outstanding. Such remaining amount in the trust account will be distributed either to (i) all holders of public shares upon our liquidation or (ii) holders of public shares who elect to have their shares redeemed in connection with the consummation of our initial business combination. On December 21, 2023, the Company received a deficiency letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”). The Letter notified the Company that since the Company had not yet filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, the Company does not comply with Nasdaq’s Listing Rule 5250(c)(1) relating to the Company’s obligation to file periodic financial reports for continued listing. The Letter further stated that the Company has until February 19, 2024 to submit a plan to regain compliance with respect to the delinquent reports. On February 6, 2024, Daniel Braatz resigned as Chairman and Chief Executive Officer of the Company. Mr. Braatz will remain as a director. Mr. Braatz informed the Company that his resignation was not the result of any disagreement with the Company related to its operations, policies or practices. On the same date, the board of directors appointed Kyle Bransfield as a director, Chairman and Chief Executive Officer of the Company. No family relationship exists between Mr. Bransfield and any of the Company’s directors or executive officers. There are no arrangements or understandings between Mr. Bransfield and any other person pursuant to which Mr. Bransfield was selected as an officer of the Company, nor are there any transactions to which the Company is or was a participant and in which Mr. Bransfield had or will have a direct or indirect material interest subject to disclosure under Item 404(a) of Regulation S-K. On February 9, 2024, the Company and Templar amended and restated the Working Capital Promissory Note (the “Amended and Restated Note”), to increase the maximum principal amount from $500,000 to $2,000,000 and to provide that, in addition to funding working capital needs, amounts under the Amended and Restated Note may be used the purposes of making one or more payments to Continental Stock Transfer & Trust Company, a New York limited liability trust company, as Extension Payments (as defined in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on November 29, 2023, as amended).

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
Summary of Significant Accounting Policies (Policies)	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $9,369 and $413,206 in cash and no cash equivalents as of September 30, 2023, and December 31, 2022, respectively.
Investments Held in Trust Account	Investment Held in Trust Account As of September 30, 2023, and December 31, 2022, the Company had $63,424,707 and $177,952,202, respectively held in the Trust Account which invests only in direct U.S. government treasury obligations.
Share-based Compensation	Share-based Compensation The transfer of the Founder Shares is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, share- based compensation associated with equity-classified awards is measured at fair value upon the grant date. The Founders Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Share-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon occurrence of a Business Combination) in an amount equal to the number of Founders Shares that ultimately vest multiplied by the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares. As of September 30, 2023, the Company determined that a Business Combination is not considered probable and, therefore, no share- based compensation expense has been recognized. The fair value at the grant date of the 40,000 Founder Shares transferred to the Company’s directors was approximately $203,000 or $5.08 per share. Upon consummation of an initial business combination, the Company will recognize approximately $203,000 in compensation expense.
Net Income Per Ordinary Share	Net Income Per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income per share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the periods. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 17,575,000 of the Company’s Class A ordinary shares in the calculation of diluted income per share. The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend for the purposes of the numerator in the earnings per share calculation. Net income per ordinary share is computed by dividing the pro rata net income between the redeemable shares and the non-redeemable shares by the weighted average number of ordinary shares outstanding for each of the periods. The calculation of diluted income per ordinary stock does not consider the effect of the warrants issued in connection with the Initial Public Offering since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except share amounts) for the three and nine months ended September 30, 2023, and 2022: For the Three Months Ended 2023 2022 Class A Ordinary Class B Ordinary Class A Ordinary Class B Ordinary Basic and diluted net income per ordinary share Numerator Allocation of net income $ 2,328,684 $ 1,553,351 $ 438,425 $ 109,606 Denominator Basic and diluted weighted average shares outstanding 6,465,022 4,312,500 17,250,000 4,312,500 Basic and diluted net income per ordinary shares $ 0.36 $ 0.36 $ 0.03 $ 0.03 For the Nine Months Ended 2023 2022 Class A Ordinary Class B Ordinary Class A Ordinary Class B Ordinary Basic and diluted net income per ordinary share Numerator: Allocation of net income $ 2,762,058 $ 1,352,683 $ 8,713,136 $ 2,178,284 Denominator Basic and diluted weighted average shares outstanding 8,805,742 4,312,500 17,250,000 4,312,500 Basic and diluted net income per ordinary shares $ 0.31 $ 0.31 $ 0.51 $ 0.51
Income Taxes	Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement re The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.
Warrant Liability	Warrant Liability The Company accounts for warrants based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, “Distinguishing Liabilities from Equity” (“ASC 480”), and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The fair value of the warrants was estimated using a Monte Carlo simulation model-based approach (see Note 11).
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, Derivatives and Hedging. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’ own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. Level 1—Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2—Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3—Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities were expensed as incurred in the condensed consolidated statements of operations. Offering costs associated with the Class A ordinary shares issued were charged to temporary equity and warrants upon the completion of the Initial Public Offering. Offering costs amounting to $10,321,097 were charged to shareholders’ equity upon the completion of the Initial Public Offering and $465,166 were expensed as of the date of the Initial Public Offering.
Recently Issued Accounting Standards	Recently Issued Accounting Standards In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholder’s equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholder’s equity section of the Company’s balance sheet.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
Summary of Significant Accounting Policies (Tables)	Sep. 30, 2023
Accounting Policies [Abstract]
Summary of Basic and Diluted Net Income Loss Per Common Share	The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except share amounts) for the three and nine months ended September 30, 2023, and 2022: For the Three Months Ended 2023 2022 Class A Ordinary Class B Ordinary Class A Ordinary Class B Ordinary Basic and diluted net income per ordinary share Numerator Allocation of net income $ 2,328,684 $ 1,553,351 $ 438,425 $ 109,606 Denominator Basic and diluted weighted average shares outstanding 6,465,022 4,312,500 17,250,000 4,312,500 Basic and diluted net income per ordinary shares $ 0.36 $ 0.36 $ 0.03 $ 0.03 For the Nine Months Ended 2023 2022 Class A Ordinary Class B Ordinary Class A Ordinary Class B Ordinary Basic and diluted net income per ordinary share Numerator: Allocation of net income $ 2,762,058 $ 1,352,683 $ 8,713,136 $ 2,178,284 Denominator Basic and diluted weighted average shares outstanding 8,805,742 4,312,500 17,250,000 4,312,500 Basic and diluted net income per ordinary shares $ 0.31 $ 0.31 $ 0.51 $ 0.51

Class A Ordinary Shares Subje_2

Class A Ordinary Shares Subject to Possible Redemption (Tables)	9 Months Ended
	Sep. 30, 2023
Temporary Equity Disclosure [Abstract]
Summary of Class A Ordinary Shares Subject to possible Redemption	At December 31, 2022 and September 30, 2023, the Class A ordinary shares subject to possible redemption reflected in the balance sheet is reconciled in the following table: Class A Ordinary Shares Subject to Possible Redemption December 31, 2022 $ 177,952,202 Less: Shares redeemed in February 2023 $ (111,346,281 ) Shares redeemed in September 2023 $ (8,273,281 ) Add: Reameasurement of carrying value to redemption value $ 5,092,067 Class A Ordinary Shares Subject to Possible Redemption September 30, 2023 $ 63,424,707

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Summary of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis	The following table presents information about the Company’s assets and liabilities that are measured at fair value at September 30, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Level September 30, 2023 December 31, 2022 Assets: Investments held in Trust Account – (1) 1 $ 63,424,707 $ 177,952,202 Liabilities: Warrant Liability - Public Warrants (2) 1 $ 322,575 $ 172,500 Warrant Liability - Private Warrants (2) 2 $ 334,730 $ 179,000 (1) The fair value of the investments held in Trust Account approximates the carrying amount primarily due to the short-term nature. (2) Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period. The estimated fair value of the Public Warrants was transferred from a Level 3 measurement to a Level I measurement during the year ended December 31, 2022, when the Public Warrants were separately listed and traded in an active market. The estimated fair value of the Private Warrants was transferred from a Level 3 measurement to a Level 2 measurement during the year ended December 31, 2022, as the key inputs to the valuation model became directly or indirectly observable from the Public Warrants listed price. There have been no transfers for the nine-month period ended September 30, 2023.
Summary of Fair Value Measurements Inputs	The key inputs into the Monte Carlo simulation model for the Private Placement Warrants and Public Warrants were as follows at initial measurement: Inputs December 9, Risk-free interest rate 1.27 % Expected term (years) 5.0 Expected volatility 15.0 % Exercise price $ 11.50 Stock price $ 9.59 The key inputs into the Monte Carlo simulation model for the Private Placement Warrants and Public Warrants were as follows at subsequent measurement: Inputs September 30, December 31, Risk-free interest rate 4.72 % 4.08 % Expected term (years) 0.58 0.83 Expected volatility 1.14 % 0.35 % Exercise price $ 11.50 $ 11.50 Stock price $ 10.97 $ 10.27
Summary of Changes in the Fair Value of Level 2 Warrant Liabilities	The following table presents the changes in the fair value of the Level 2 warrant liabilities: Private Placement Fair value as of December 31, 2022 $ 179,000 Change in valuation inputs or other assumptions 155,730 Fair value as of September 30, 2023 $ 334,730

Description Of Organization, _2

Description Of Organization, And Business Operations And Going Concern - Additional Information (Detail) - USD ($)							3 Months Ended			9 Months Ended		12 Months Ended
	Dec. 08, 2023	Sep. 08, 2023	Sep. 07, 2023	Aug. 18, 2023	Feb. 27, 2023	Dec. 09, 2021	Dec. 09, 2023	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 09, 2024	Feb. 09, 2024	Jan. 10, 2024	Dec. 20, 2023	Nov. 13, 2023	Oct. 19, 2023	Sep. 15, 2023	Aug. 22, 2023	Jun. 22, 2023	May 26, 2023	Mar. 01, 2023	Feb. 28, 2023	Dec. 31, 2022	Oct. 17, 2022	May 21, 2021
Transaction cost						$ 10,321,097				$ 10,321,097
Underwriting expense paid						3,450,000
Deferred underwriting fee payable noncurrent						6,037,500
Offering cost						$ 833,597
Payment to acquire restricted investments										1,625,000	$ 0
Restricted investments term						185 days
Dissolution expense										100,000
Cash								$ 9,369		9,369														$ 413,206
Working capital (deficit)								167,889		167,889
Cash held outside trust account						$ 1,295,936
Operating cash								9,369		9,369
Working capital loan								167,889		167,889
Asset held in trust account								63,424,707		63,424,707													$ 68,271,081	$ 177,952,202
Amount deposited into Trust Account for extension of the termination date																$ 125,000	$ 125,000	$ 125,000		$ 750,000		$ 750,000
Repayments of Notes Payable				$ 1,625,000						1,625,000	0
Gain (Loss) on Extinguishment of Debt				$ 117,373				$ 117,373	$ 0	$ 117,373	$ 0
Class of warrant or right, outstanding								17,575,000		17,575,000
M&A advisory services [Member] \| EarlyBirdCapital, Inc. [Member]
Transaction Fee payable																									$ 2,000,000
Percentage of placement agent fee on equity investment																									4.50%
Percentage of placement agent fee on debt financing amount																									2.50%
M&A advisory services [Member] \| EarlyBirdCapital, Inc. [Member] \| Letter Amendment [Member]
Transaction Fee payable																			$ 500,000
Promissory Note [Member]
Debt Instrument, Face Amount																							$ 875,000
Second Promissory Note [Member]
Debt Instrument, Face Amount																					$ 750,000
Working Capital Promissory Note [Member]
Debt Instrument, Face Amount		$ 500,000						$ 125,000		$ 125,000
Subsequent Event [Member]
Amount deposited into Trust Account for extension of the termination date													$ 125,000	$ 125,000	$ 125,000	$ 125,000	$ 125,000
Sponsor [Member]
Minimum public share price due to reductions in the value of the trust assets less taxes payable										$ 10
Sponsor [Member] \| Founder Shares [Member]
Common stock shares outstanding		970,312
Sponsor [Member] \| Promissory Note [Member]
Debt Instrument, Face Amount																										$ 300,000
Sponsor [Member] \| Purchase Agreement [Member]
Amount of funds transferred in exchange of warrants or other instruments		$ 1
Amount of transaction to pay expenses		$ 50,000
Related Party [Member]
Due from related parties								25,000		$ 25,000
Due to related parties current								$ 0		$ 0
Minimum [Member]
Percentage of fair market value of target business to asset held in trust account								80%		80%
Percentage of redeeming shares of public shares without the company's prior written consent								15%		15%
Minimum [Member] \| Post Business Combination [Member]
Percentage of voting interests acquired								50%		50%
Private Placement Warrants [Member]
Class of warrants and rights issued during the period						8,950,000
Number of securities called by each warrant or right						11.5
Class of warrants and rights issued, price per warrant						$ 1
Proceeds from issuance of private placement						$ 8,950,000
Class of warrant or right, outstanding								8,950,000		8,950,000
Private Placement Warrants [Member] \| Sponsor [Member]
Class of warrants and rights issued during the period		6,936,250
Class of warrant or right, outstanding		2,013,750
IPO [Member]
Number of shares issued in transaction						17,250,000
Share price						$ 10
Proceeds from issuance initial public offering						$ 172,500,000
Transaction cost						10,321,097
Underwriting expense paid						3,450,000
Deferred underwriting fee payable noncurrent						6,037,500
Offering cost						833,897
Payment to acquire restricted investments						$ 175,950,000
IPO [Member] \| Minimum [Member]
Share price								$ 10		$ 10
Common Class A [Member]
Common stock shares issued								200,000		200,000														200,000
Common stock shares outstanding								200,000		200,000														200,000
Common stock par or stated value per share								$ 0.0001		$ 0.0001														$ 0.0001
Common Class A [Member] \| IPO [Member]
Number of shares issued in transaction						17,250,000
Share price						$ 10
Proceeds from issuance initial public offering						$ 172,500,000
Number of securities called by each warrant or right								1		1
Common Class B [Member]
Common stock shares issued								4,312,500		4,312,500														4,312,500
Common stock shares outstanding								4,312,500		4,312,500														4,312,500
Common stock par or stated value per share								$ 0.0001		$ 0.0001														$ 0.0001
Common Class B [Member] \| Sponsor [Member] \| Founder Shares [Member]
Stock issued during period shares		3,342,188
Common stock par or stated value per share		$ 0.0001
Public shares [Member]
Share price								$ 10		$ 10
Payment to acquire restricted investments							$ 125,000					$ 125,000
Shares exercised, during the period	201,496		757,463		10,693,417
Aggregate redemption amount	$ 2,246,585		$ 8,273,281		$ 111,346,281
Asset held in trust account	$ 62,410,856		$ 63,340,058		$ 68,271,081
Common stock shares issued	5,597,624		5,799,120		6,556,583
Common stock shares outstanding	5,597,624		5,799,120		6,556,583
Minimum deposit in restricted investments based on public share price							$ 0.025					$ 0.025
Public shares [Member] \| Subsequent Event [Member]
Payment to acquire restricted investments	$ 125,000
Shares exercised, during the period	201,496
Aggregate redemption amount	$ 2,246,585
Asset held in trust account	$ 62,410,856
Common stock shares issued	5,597,624
Common stock shares outstanding	5,597,624
Minimum deposit in restricted investments based on public share price	$ 0.025

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Income Loss Per Common Share (Detail) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
EPS
Allocation of net income	$ 3,882,035	$ 111,861	$ 120,845	$ 548,031	$ 2,682,422	$ 7,660,967	$ 4,114,741	$ 10,891,420
Diluted weighted average shares outstanding							17,575,000
Common Class A [Member]
EPS
Allocation of net income	$ 2,328,684			$ 438,425			$ 2,762,058	$ 8,713,136
Basic weighted average shares outstanding	6,465,022			17,250,000			8,805,742	17,250,000
Diluted weighted average shares outstanding	6,465,022			17,250,000			8,805,742	17,250,000
Basic net income per ordinary share	$ 0.36			$ 0.03			$ 0.31	$ 0.51
Diluted net income per ordinary share	$ 0.36			$ 0.03			$ 0.31	$ 0.51
Common Class B [Member]
EPS
Allocation of net income	$ 1,553,351			$ 109,606			$ 1,352,683	$ 2,178,284
Basic weighted average shares outstanding	4,312,500			4,312,500			4,312,500	4,312,500
Diluted weighted average shares outstanding	4,312,500			4,312,500			4,312,500	4,312,500
Basic net income per ordinary share	$ 0.36			$ 0.03			$ 0.31	$ 0.51
Diluted net income per ordinary share	$ 0.36			$ 0.03			$ 0.31	$ 0.51

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)		9 Months Ended
	Dec. 09, 2021	Sep. 30, 2023	Feb. 28, 2023	Dec. 31, 2022
Cash		$ 9,369		$ 413,206
Cash equivalents at carrying value		0		0
Asset held in trust account		$ 63,424,707	$ 68,271,081	$ 177,952,202
Weighted average number of shares outstanding diluted		17,575,000
Unrecognized tax benefits		$ 0
Accrued for interest and penalties		0
FDIC Insured Amount		250,000
Transaction cost	$ 10,321,097	10,321,097
Other Offering Cost		465,166
Share Based Compensation expense		$ 0
Consummation of an Initial Business Combination Event [Member] \| Board of Directors [Member]
Stock options shares granted		40,000
Stock options fair value		$ 203,000
Grant date fair value per share		$ 5.08
Compensation expense		$ 203,000

Initial Public Offering -Additi

Initial Public Offering -Additional Information (Detail) - USD ($)			3 Months Ended	9 Months Ended
	Sep. 28, 2022	Dec. 09, 2021	Sep. 30, 2022	Sep. 30, 2023
Transaction cost		$ 10,321,097		$ 10,321,097
Underwriting expense paid		3,450,000
Deferred underwriting fee payable noncurrent		6,037,500
Offering cost		$ 833,597
Deferred underwriting commission waived	$ 6,037,500		$ 6,037,500
IPO [Member]
Number of Shares Issued in Transaction		17,250,000
Share price		$ 10
Proceeds from issuance initial public offering		$ 172,500,000
Transaction cost		10,321,097
Underwriting expense paid		3,450,000
Deferred underwriting fee payable noncurrent		6,037,500
Offering cost		$ 833,897
Common Class A [Member] \| IPO [Member]
Number of Shares Issued in Transaction		17,250,000
Share price		$ 10
Proceeds from issuance initial public offering		$ 172,500,000
Shares issuable				1
Shares Issued, Price Per Share				$ 0.0001
Common Class A [Member] \| Public Warrants [Member] \| IPO [Member]
Stock Conversion Basis				one redeemable warrant
Exercise price of warrants or rights				$ 11.5

Private Placement - Additional

Private Placement - Additional Information (Detail) - USD ($)	Sep. 08, 2023	Dec. 09, 2021	Sep. 30, 2023
Class of warrant or right, outstanding			17,575,000
Common Class A [Member] \| Share Price Equal or Exceeds Eighteen Rupees per dollar [Member]
Share price			$ 18
Private Placement Warrants [Member]
Class of warrants and rights issued during the period		8,950,000
Class of warrants and rights issued, price per warrant		$ 1
Proceeds from private placement		$ 8,950,000
Class of warrant or right, outstanding			8,950,000
Private Placement Warrants [Member] \| Sponsor [Member]
Class of warrants and rights issued during the period	6,936,250
Class of warrant or right, outstanding	2,013,750

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)			9 Months Ended
	Sep. 08, 2023	May 21, 2021	Sep. 30, 2023	Feb. 28, 2023	Dec. 31, 2022
Working Capital Loan [Member]
Debt instrument convertible into warrants			$ 1,500,000
Debt instrument conversion price			$ 1
Promissory Note [Member]
Debt instrument face amount				$ 875,000
Founder Shares [Member]
Common stock threshold percentage on conversion of shares			20%
Common Class B [Member]
Common stock shares outstanding			4,312,500		4,312,500
Common stock par or stated value per share			$ 0.0001		$ 0.0001
Common Class A [Member]
Common stock shares outstanding			200,000		200,000
Common stock par or stated value per share			$ 0.0001		$ 0.0001
Sponsor [Member] \| Interse Transfer Of Shares [Member] \| Apx Cap Sponsor Group LLC [Member]
Common stock shares outstanding	970,312
Sponsor [Member] \| Office Space, Administrative and Support Services [Member]
Related party transaction amounts of transaction			$ 10,000
Sponsor [Member] \| Promissory Note [Member]
Debt instrument face amount		$ 300,000
Debt instrument maturity date		May 01, 2022
Debt instrument interest rate		0%
Sponsor [Member] \| Founder Shares [Member]
Shares issued shares share-based payment arrangement forfeited		562,500
Common stock threshold percentage on conversion of shares		20%
Common stock shares outstanding	970,312
Sponsor [Member] \| Common Class B [Member] \| Founder Shares [Member]
Stock issued during period shares issued for services		4,312,500
Stock issued during period value issued for services		$ 25,000
Shares issued shares share-based payment arrangement forfeited			0
Stock issued during period shares	3,342,188
Common stock par or stated value per share	$ 0.0001
Sponsor [Member] \| Common Class A [Member] \| Share Price More Than Or Equals To USD Twelve [Member]
Share transfer trigger price per share			$ 12
Number of consecutive trading days for determining share price			20 days
Number of trading days for determining share price			30 days
Threshold number of trading days for determining share price from date of business combination			120 days

Promissory Note Payable - Addit

Promissory Note Payable - Additional Information (Detail) - USD ($)			3 Months Ended		9 Months Ended		12 Months Ended
	Dec. 31, 2023	Aug. 18, 2023	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Sep. 08, 2023	May 26, 2023	Feb. 28, 2023
Debt Instrument [Line Items]
Class Of Warrants Or Rights Issued During The Period							750,000
Ending debt discount			$ 0		$ 0
Repayments of Notes Payable		$ 1,625,000			1,625,000	$ 0
Gain (Loss) on Extinguishment of Debt		$ 117,373	117,373	$ 0	117,373	$ 0
Promissory Note [Member]
Debt Instrument [Line Items]
Debt instrument face amount										$ 875,000
Promissory Note [Member] \| First Extension [Member]
Debt Instrument [Line Items]
Debt instrument face amount										$ 125,000
Promissory Note [Member] \| Subsequent Event [Member]
Debt Instrument [Line Items]
Debt Conversion, Converted Instrument, Warrants or Options Issued	875,000
Second Promissory Note [Member]
Debt Instrument [Line Items]
Debt instrument face amount									$ 750,000
Working Capital Promissory Note [Member]
Debt Instrument [Line Items]
Debt instrument face amount			$ 125,000		$ 125,000			$ 500,000

Commitments And Contingencies -

Commitments And Contingencies - Additional Information (Detail) - USD ($)			3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 28, 2022	Dec. 09, 2021	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Underwriting expense paid		$ 3,450,000
Deferred underwriting fee payable noncurrent		$ 6,037,500
Deferred Underwriting Commission Waived	$ 6,037,500			$ 6,037,500
Gain On Settlement Of Underwriting Fees					$ 0	$ 5,788,453	$ 5,788,453
Gain Loss On Settlement Of Deferred Underwriting Fees			$ 0	$ 249,047	0	$ 249,047	$ 249,047
Outstanding deferred underwriting commission			$ 0		0
Structuring Services Agreement [Member]
Customary Fees Outstanding					$ 0
Over-Allotment Option [Member]
Over allotment option period		45 days
Stock issued during period shares		2,250,000
Underwriter cash discount		2%
Underwriting expense paid		$ 3,450,000
Percentage of deferred underwriting commission		3.50%
Deferred underwriting fee payable noncurrent		$ 6,037,500

Warrant Liability - Additional

Warrant Liability - Additional Information (Detail)	9 Months Ended
Warrant Liability - Additional Information (Detail)	Sep. 30, 2023 $ / shares shares
Class of Warrant or Right [Line Items]
Number of warrants or rights outstanding \| shares	17,575,000
Share Price Equal or Exceeds Eighteen Rupees per dollar [Member]
Class of Warrant or Right [Line Items]
Share redemption trigger price	$ 18
Class of warrant or right exercise price adjustment percentage higher of market value	180%
Share Price Equal or Exceeds Eighteen Rupees per dollar [Member] \| Common Class A [Member]
Class of Warrant or Right [Line Items]
Share price	$ 18
Share Price Equal or Exceeds Eighteen Rupees per dollar [Member] \| Common Class A [Member] \| Minimum [Member]
Class of Warrant or Right [Line Items]
Share price	$ 18
Share Price Equal or Less Nine point Two Rupees per dollar [Member]
Class of Warrant or Right [Line Items]
Class of warrant or right exercise price adjustment percentage higher of market value	115%
Share Price Equal or Less Nine point Two Rupees per dollar [Member] \| Common Class A [Member]
Class of Warrant or Right [Line Items]
Share redemption trigger price	$ 9.2
Minimum Percentage Gross Proceeds Required From Issuance Of Equity	60%
Class of warrant or right minimum notice period for redemption	20 days
Class of warrant or right exercise price of warrants or rights	$ 9.2
Share Price Equal or Exceeds Ten point Zero Rupees per dollar [Member] \| Common Class A [Member]
Class of Warrant or Right [Line Items]
Share price	$ 10
Public Warrants [Member]
Class of Warrant or Right [Line Items]
Number of warrants or rights outstanding \| shares	8,625,000
Warrants exercisable term from the date of completion of business combination	30 days
Warrants exercisable term from the closing of IPO	12 months
Minimum lock in period for sec registration from date of business combination	15 days
Private Placement Warrants [Member]
Class of Warrant or Right [Line Items]
Number of warrants or rights outstanding \| shares	8,950,000
Redemption Of Warrants [Member] \| Common Class A [Member]
Class of Warrant or Right [Line Items]
Class of warrants redemption period	30 days
Redemption Of Warrants [Member] \| Share Price Equal or Exceeds Eighteen Rupees per dollar [Member] \| Common Class A [Member]
Class of Warrant or Right [Line Items]
Class of warrants redemption price per unit	$ 0.01
Class of warrants redemption notice period	30 days
Class of warrants redemption period	30 days
Share price	$ 18
Redemption Of Warrants [Member] \| Share Price Equal or Exceeds Eighteen Rupees per dollar [Member] \| Common Class A [Member] \| Minimum [Member]
Class of Warrant or Right [Line Items]
Class of warrant or right minimum notice period for redemption	20 days
Redemption Of Warrants [Member] \| Share Price Equal or Exceeds Eighteen Rupees per dollar [Member] \| Common Class A [Member] \| Maximum [Member]
Class of Warrant or Right [Line Items]
Number of consecutive trading days for determining share price	30 days
Redemption Of Warrants [Member] \| Share Price Equal or Exceeds Ten point Zero Rupees per dollar [Member] \| Common Class A [Member]
Class of Warrant or Right [Line Items]
Class of warrants redemption price per unit	$ 0.1
Class of warrants redemption notice period	30 days

Shareholders' Deficit - Additio

Shareholders' Deficit - Additional Information (Detail) - $ / shares	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Preferred stock shares authorized	1,000,000	1,000,000
Preferred stock par or stated value per share	$ 0.0001	$ 0.0001
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Founder Shares [Member]
Common stock threshold percentage on conversion of shares	20%
Common Class B [Member]
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	20,000,000	20,000,000
Common stock shares issued	4,312,500	4,312,500
Common stock shares outstanding	4,312,500	4,312,500
Common stock, voting rights	one vote

Class A Ordinary Shares Subje_3

Class A Ordinary Shares Subject to Possible Redemption - Summary of Class A Ordinary Shares Subject to Possible Redemption (Detail) - USD ($)			9 Months Ended
	Sep. 30, 2023	Feb. 28, 2023	Sep. 30, 2023	Dec. 31, 2022
Temporary Equity [Line Items]
Class A Ordinary Shares Subject to Possible Redemption	$ 63,424,707		$ 63,424,707	$ 177,952,202
Shares redeemed in February 2023	(8,273,281)	$ (111,346,281)
Class A Ordinary Shares Subject to Possible Redemption [Member]
Temporary Equity [Line Items]
Class A Ordinary Shares Subject to Possible Redemption	$ 63,424,707		63,424,707	$ 177,952,202
Shares redeemed in February 2023			(111,346,281)
Shares redeemed in September 2023			(8,273,281)
Reameasurement of carrying value to redemption value			$ 5,092,067

Class A Ordinary Shares Subje_4

Class A Ordinary Shares Subject to Possible Redemption - Additional Information (Detail) - USD ($)	Sep. 30, 2023	Feb. 28, 2023	Nov. 13, 2023	Oct. 19, 2023	Sep. 15, 2023	Jun. 22, 2023	Mar. 01, 2023	Dec. 31, 2022
Temporary Equity Stock Redeemed During The Period Shares	757,463	10,693,417
Cash Withdrawn from Trust Account Per Share for Redemption Of Shares	$ 10.92	$ 10.41
Cash Withdrawn from Trust Account for Redemption Of Temporary Equity	$ 8,273,281	$ 111,346,281
Temporary equity, shares issued	5,799,120	6,556,583
Temporary equity shares outstanding	5,799,120	6,556,583						17,250,000
Asset held in trust account	$ 63,424,707	$ 68,271,081						$ 177,952,202
Amount deposited into Trust Account for extension of the termination date			$ 125,000	$ 125,000	$ 125,000	$ 750,000	$ 750,000

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis (Detail) - USD ($)		Sep. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments held in Trust Account		$ 63,424,707	$ 177,952,202
Warrant liability		657,305	351,500
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments held in Trust Account	[1]	63,424,707	177,952,202
Fair Value, Inputs, Level 1 [Member] \| Public Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	[2]	322,575	172,500
Fair Value, Inputs, Level 2 [Member] \| Private Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	[2]	$ 334,730	$ 179,000

[1]The fair value of the investments held in Trust Account approximates the carrying amount primarily due to the short-term nature.[2]Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period. The estimated fair value of the Public Warrants was transferred from a Level 3 measurement to a Level I measurement during the year ended December 31, 2022, when the Public Warrants were separately listed and traded in an active market. The estimated fair value of the Private Warrants was transferred from a Level 3 measurement to a Level 2 measurement during the year ended December 31, 2022, as the key inputs to the valuation model became directly or indirectly observable from the Public Warrants listed price. There have been no transfers for the nine-month period ended September 30, 2023.

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Fair Value Measurements Inputs (Detail)	Sep. 30, 2023 yr	Dec. 31, 2022 yr	Dec. 09, 2021 yr
Risk-free interest rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	4.72	4.08	1.27
Expected term (years) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.58	0.83	5
Expected Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	1.14	0.35	15
Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	11.5	11.5	11.5
Share Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	10.97	10.27	9.59

Fair Value Measurements - Sum_3

Fair Value Measurements - Summary of Changes in the Fair Value of Level 3 Warrant Liabilities (Detail) - Fair Value, Inputs, Level 2 [Member] - Private Placement Warrants [Member]	9 Months Ended
	Sep. 30, 2023 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance	$ 179,000
Change in valuation inputs or other assumptions	155,730
Ending balanace	$ 334,730

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - USD ($)									3 Months Ended	9 Months Ended		12 Months Ended
	Feb. 09, 2024	Jan. 10, 2024	Dec. 08, 2023	Nov. 10, 2023	Oct. 16, 2023	Oct. 02, 2023	Sep. 07, 2023	Feb. 27, 2023	Dec. 09, 2023	Sep. 30, 2023	Sep. 30, 2022	Dec. 09, 2024	Dec. 20, 2023	Nov. 13, 2023	Oct. 19, 2023	Sep. 15, 2023	Sep. 08, 2023	Jun. 22, 2023	Mar. 01, 2023	Feb. 28, 2023	Dec. 31, 2022
Subsequent Event [Line Items]
Asset held in trust account										$ 63,424,707										$ 68,271,081	$ 177,952,202
Payment to acquire restricted investments										1,625,000	$ 0
Amount deposited into Trust Account for extension of the termination date														$ 125,000	$ 125,000	$ 125,000		$ 750,000	$ 750,000
Public shares [Member]
Subsequent Event [Line Items]
Asset held in trust account			$ 62,410,856				$ 63,340,058	$ 68,271,081
Minimum deposit in restricted investments based on public share price									$ 0.025			$ 0.025
Payment to acquire restricted investments									$ 125,000			$ 125,000
Shares exercised, during the period			201,496				757,463	10,693,417
Aggregate redemption amount			$ 2,246,585				$ 8,273,281	$ 111,346,281
Common stock shares outstanding			5,597,624				5,799,120	6,556,583
Common stock shares issued			5,597,624				5,799,120	6,556,583
Working Capital Promissory Note [Member]
Subsequent Event [Line Items]
Debt Instrument, Face Amount										$ 125,000							$ 500,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Amount deposited into Trust Account for extension of the termination date	$ 125,000	$ 125,000											$ 125,000	$ 125,000	$ 125,000
Subsequent Event [Member] \| Public shares [Member]
Subsequent Event [Line Items]
Asset held in trust account			$ 62,410,856
Minimum deposit in restricted investments based on public share price			$ 0.025
Payment to acquire restricted investments			$ 125,000
Shares exercised, during the period			201,496
Aggregate redemption amount			$ 2,246,585
Common stock shares outstanding			5,597,624
Common stock shares issued			5,597,624
Subsequent Event [Member] \| Common Class A [Member]
Subsequent Event [Line Items]
Conversion of Stock, Shares Issued						4,312,500
Subsequent Event [Member] \| Common Class B [Member]
Subsequent Event [Line Items]
Conversion of Stock, Shares Converted						4,312,500
Subsequent Event [Member] \| Working Capital Promissory Note [Member]
Subsequent Event [Line Items]
Additional Borrowings in Aggregate Debt	125,000	$ 125,000	$ 125,000	$ 125,000	$ 125,000
Subsequent Event [Member] \| Working Capital Promissory Note [Member] \| Minimum [Member]
Subsequent Event [Line Items]
Debt Instrument, Face Amount	500,000
Subsequent Event [Member] \| Working Capital Promissory Note [Member] \| Maximum [Member]
Subsequent Event [Line Items]
Debt Instrument, Face Amount	$ 2,000,000